Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026)
Cartesian Therapeutics' EBITDA came in at -$28.38 million for Q2 2026, compared with -$21.22 million a year earlier.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cartesian Therapeutics reported EBITDA of -$152.75 million; for FY2025, it came in at -$140.45 million.
- Going back by year, EBITDA was -$42.75 million in FY2024, -$85.57 million in FY2023, $15.83 million in FY2022 and -$3.35 million in FY2021.
- The five-year range for quarterly EBITDA is -$78.03 million (Q4 2025) to $14.21 million (Q2 2022).
- Business Quant data shows RNAC's EBITDA at -$25.88 million (Q1 2026), -$78.03 million (Q4 2025) and -$20.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | -28.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.38 Mn |
| Mar 31, 2026 | -25.88 Mn |
| Dec 31, 2025 | -78.03 Mn |
| Sep 30, 2025 | -20.46 Mn |
| Jun 30, 2025 | -21.22 Mn |
| Mar 31, 2025 | -20.73 Mn |
| Dec 31, 2024 | -26.25 Mn |
| Sep 30, 2024 | -17.29 Mn |
| Jun 30, 2024 | 13.95 Mn |
| Mar 31, 2024 | -13.17 Mn |
| Dec 31, 2023 | -36.06 Mn |
| Sep 30, 2023 | -12.88 Mn |
| Jun 30, 2023 | -18.46 Mn |
| Mar 31, 2023 | -18.18 Mn |
| Dec 31, 2022 | -8.26 Mn |
| Sep 30, 2022 | -1.25 Mn |
| Jun 30, 2022 | 14.21 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | -1.63 Mn |
API Access
Cartesian Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();